Latest News

Filters close
Released: 24-Jan-2023 9:45 AM EST
Announcing The 2023 Franklin Institute Awards Laureates
Franklin Institute

The Franklin Institute is proud to announce nine outstanding individuals being honored with a prestigious Franklin Institute Award for their extraordinary scientific, engineering, and business leadership achievements.

Released: 23-Jan-2023 9:00 AM EST
BillionToOne appoints Dr. Gary Palmer as Chief Medical Officer, Oncology; Launches Northstar Select™ and Northstar Response™ Liquid Biopsy Assays for Commercial Use

Dr. Palmer brings significant expertise both as a clinical oncologist and as a high-level executive at several national laboratories. His prior industry roles include CMO at Tempus Labs, VP of Medical Affairs at Foundation Medicine, and VP of Medical Affairs at Genomic Health.

Released: 19-Jan-2023 11:20 AM EST
The New York Genome Center Launches the MacMillan Center for the Study of the Non-Coding Cancer Genome
New York Genome Center

The New York Genome Center (NYGC) announced the launch of the MacMillan Center for the Study of the Non-Coding Cancer Genome (MCSNCG) today, a major new initiative in cancer research to study the role and function of the non-coding genome and epigenome in the evolution, progression, and treatment of multiple cancer types, including breast, ovary, pancreas, gastrointestinal, lung, and hematologic cancers.

Released: 18-Jan-2023 9:00 AM EST
CeCe Migraine Management App Syncs With CEFALY Connected Device to Provide Personalized Migraine Insights
Cefaly Technology

The award-winning CeCe Migraine Management app now offers users an unprecedented level of insight into their migraine treatments with the CEFALY Connected device.

Released: 18-Jan-2023 8:40 AM EST
APRINOIA Therapeutics and ROSS Acquisition Corp II Announce Business Combination Agreement to Create Publicly Listed Company Focused on Neurodegenerative Diseases
Ross Acquisition Corp II

APRINOIA Therapeutics Inc. ("APRINOIA"), a clinical-stage biotechnology company focused on neurodegenerative diseases such as Alzheimer's Disease ("AD") and Progressive Supranuclear Palsy ("PSP"), and Ross Acquisition Corp II (NYSE: ROSS, ROSS.U, ROSS WS) ("ROSS"), a special purpose acquisition company founded by former Commerce Secretary Wilbur Ross, today announced that they have entered into a definitive agreement (the "Business Combination Agreement") for a business combination (the "Business Combination").

Released: 12-Jan-2023 12:45 PM EST
Submissions Due February 24 for the 2023 Hearst Health Prize in Partnership with the UCLA Center for SMART Health
Hearst Health

Hearst Health, in partnership with the UCLA Center for SMART Health, today announced that the call for submissions is open for the 2023 Hearst Health Prize, an annual award that recognizes data science projects and programs demonstrating improved health outcomes for U.S. populations.

Released: 10-Jan-2023 8:55 AM EST
Arthrex Receives FDA Clearance for TightRope® Implant as First, Only Device Cleared for Pediatric ACL Surgery
Arthrex, Inc.

Arthrex, a global leader in minimally invasive surgical technology, announced today its ACL TightRope implant has received clearance from the U.S. Food and Drug Administration (FDA) for pediatric indications.

Released: 9-Jan-2023 8:15 AM EST
Stuart Therapeutics, Inc., announces expansion of its development pipeline, additions to its Scientific Advisory Board
Stuart Therapeutics

Stuart Therapeutics, Inc. announces that it has expanded its drug development pipeline, adding programs in diabetic macular edema and myopia.

Released: 3-Jan-2023 2:10 PM EST
Stuart Therapeutics, Inc. announces licensing agreement with Aju Pharm Co. Ltd.
Stuart Therapeutics

Stuart Therapeutics, Inc., (hereinafter Stuart) announces that it has entered into a license agreement with AJU Pharm Co. Ltd. (hereinafter AJU), for Stuart's clinical stage drug candidate ST-100.

Released: 27-Dec-2022 8:30 AM EST
ApolloMD and Cascade365 Partner with RIP Medical Debt to Relieve Patient Debt

ApolloMD announces a partnership with Cascade365 to work in concert with RIP Medical Debt, resulting in the successful abolishment of more than $350M of patient medical debt spanning over 800,000 patient accounts. Recipients of debt abolishment began receiving notification by way of a RIP branded letter beginning in the month of June.

Released: 21-Dec-2022 12:35 PM EST
Golden State Dermatology Expands Their Network in Sacramento
Golden State Dermatology

Golden State Dermatology (GSD) is pleased to announce a new partnership with the dermatology practice of Emil Tanghetti, MD located in Sacramento, CA. The new partnership expands GSD's network to 28 practices across the San Francisco Bay and California's Central Valley and Sacramento Valley.

Released: 20-Dec-2022 9:35 AM EST
CEFALY Technology Launches Trade-In Program for Purchasers of the New CEFALY Connected Migraine Treatment Device
Cefaly Technology

Medical device maker CEFALY Technology has announced that owners of older CEFALY devices can trade them in for credit toward the purchase of the all-new CEFALY Connected.

Released: 15-Dec-2022 10:25 AM EST
CEFALY Technology Introduces Bluetooth-Enabled CEFALY Connected Migraine Treatment Device
Cefaly Technology

Medical device maker CEFALY Technology today unveiled the newest evolution of its FDA-cleared migraine treatment device: the CEFALY Connected.

Released: 7-Dec-2022 11:00 AM EST
AnX Robotica Partners with GastroGPO, a Specialty Networks Company
AnX Robotica

AnX Robotica Corporation (, the developer and manufacturer of the NaviCam® Magnetically Controlled Capsule Endoscopy System (MCCE), is pleased to announce a partnership with GastroGPO, a Specialty Networks Company.

Released: 1-Dec-2022 9:30 AM EST
A $500 Vasectomy (Including Consultation)

DrSnip, a new vasectomy clinic in Portland, is offering a limited time discounted vasectomy for any patients who do not have insurance, or whose plans are not contracted with DrSnip.

Released: 29-Nov-2022 11:20 AM EST
Petfood Consumer Rights Council Launches, Announces Founding Member Drive
The Petfood Consumer Rights Council

The Petfood Consumer Rights Council, a first-of-its-kind consumer protection and animal welfare organization, has launched and announced its first key initiative, a 90-day founding member drive.

Released: 29-Nov-2022 8:05 AM EST
Jurata Thin Film Raises $5 Million Seed Round
Jurata Thin Film

Jurata Thin Film, a startup focused on stabilizing vaccines at ambient temperature has raised initial investment funds totaling $4.87 million to develop the technology.

Released: 28-Nov-2022 8:45 AM EST
Arthrex, Richard Wolf Announce Partnership to Expand Comprehensive Operative Care Solutions
Arthrex, Inc.

Arthrex and Richard Wolf, global leaders in minimally invasive surgical technology and solutions, announced a U.S.-based partnership to offer comprehensive technology and product offerings in urology, gynecology and general surgery.

Released: 23-Nov-2022 12:15 PM EST
Nyra Medical Announces $20 Million Series A Financing for its Transcatheter Heart Valve Repair Technology
Nyra Medical, Inc

Nyra Medical, Inc., a medical device company that is developing a novel transcatheter mitral valve repair technology, today announced the closing of a $20 million Series A financing.

Released: 22-Nov-2022 8:55 AM EST
FDA Clears the Accure Laser System for the Treatment of Mild to Severe Inflammatory Acne Vulgaris
Accure Acne, Inc.

Accure Acne, Inc. (, a pioneer in the development of innovative solutions for the treatment of acne, announced today it has received FDA clearance for its Accure Laser™ System to treat mild to severe inflammatory acne vulgaris.

Released: 16-Nov-2022 12:35 PM EST
MIM Software Inc. Releases Version 1.1.3 for Contour ProtégéAI Auto-Contouring Software
MIM Software Inc.

MIM Software Inc., a leading global provider of medical imaging software, announced today it has released a new version of its AI auto-contouring solution, Contour ProtégéAI™ Version 1.1.3.

Released: 16-Nov-2022 9:40 AM EST
LI-COR Announces the LI-7825 CO2 Isotope Trace Gas Analyzer
LI-COR Environmental

CO2 isotope measurements are a critical tool for studying climate change and for modelling future climate scenarios.

Released: 15-Nov-2022 12:05 AM EST
RareCyte® selected for the Wellcome Leap In Utero program; will utilize its rare cell liquid biopsy platform to perform breakthrough research to decrease stillbirth rates worldwide
RareCyte, Inc.

RareCyte Inc., ("RareCyte" or "The Company") a leading provider of Precision Biology products and services has been selected by Wellcome Leap to participate in the $50M In Utero program to create the scalable capacity to measure, model and predict gestational development, to achieve the goal of reducing global stillbirth rates by half.

Released: 14-Nov-2022 2:35 PM EST
Unlikely Collaborators Partners with SIY Global with Significant Investment
Unlikely Collaborators

Unlikely Collaborators has made a significant monetary investment in SIY Global, kicking-off a partnership that will see the two companies working together in a myriad of ways, including product and curriculum development, teacher training, and content creation.

Released: 11-Nov-2022 12:05 PM EST
MedStar Health Researchers Examine Alleged Misrepresentation of EHR Capabilities with Potentially Far-Reaching Patient Safety Implications
MedStar Health

Researchers at MedStar Health, Brigham and Women's Hospital, and the University of Utah found electronic health record (EHR) vendor misconduct may have led to widespread use of suboptimal products for more than 70,000 clinicians across the country, as published today in JAMA Health Forum.

Released: 9-Nov-2022 12:05 PM EST
Hyperproof releases new enterprise ready functionality to support efficient compliance operations in complex environments

Hyperproof, a pioneer in SaaS based security and compliance operations management, announced today the release of a suite of new functionality to help global enterprise organizations operating in complex environments manage their risks and compliance programs at scale.

Released: 9-Nov-2022 10:45 AM EST
Resolve Therapeutics Completes Enrollment of Phase 2 Long Covid Clinical Trial
Resolve Therapeutics, LLC

Resolve Therapeutics, pioneering first-in-class, targeted, safe therapies for underserved autoimmune diseases, today announced that its phase 2 clinical trial of RSLV-132 in patients with long covid has been fully enrolled (NCT04944121).

Released: 9-Nov-2022 10:35 AM EST
The GastroIntestinal Research Foundation Launches New Multi-Million Dollar Funding Initiative Aimed at Curing Cancers of the Digestive System
GastroIntestinal Research Foundation

Despite centuries of research, treating and curing cancer remains an urgent health research priority. With generous support from anonymous donors, the GastroIntestinal Research Foundation (GIRF) has launched a bold initiative, CA CURE, to identify and fund research to improve diagnostics and develop therapeutics focused on immunotherapies and personalized vaccines.

Released: 8-Nov-2022 10:20 AM EST
Somatus First Kidney Care Company to Achieve Certification for Claim of Improved Patient Outcomes from Validation Institute

Somatus, the nation's leading and largest value-based kidney care company, has received a 2022 Validation Program Report certifying the claim that kidney disease patients who receive Somatus Transition of Care Assessment (TCA) services have fewer hospital readmissions than similar patients who do not receive TCA services.

Released: 2-Nov-2022 8:05 AM EDT
Ahead Study Is First to Test Lecanemab to Delay or Prevent Alzheimer's Disease Symptoms at the Stage of Preclinical AD
Alzheimer's Clinical Trials Consortium

The Alzheimer's Clinical Trial Consortium (ACTC) will be presenting analyses of screening plasma and neuroimaging data from the AHEAD Study at CTAD in November.

Released: 1-Nov-2022 8:35 AM EDT
MIM Software Inc. Receives Health Canada Approval for AI Auto-Contouring Software
MIM Software Inc.

MIM Software Inc., a leading global provider of medical imaging software, announced today it has received approval from Health Canada for its AI auto-contouring solution, Contour ProtégéAI™.

Released: 28-Oct-2022 1:20 PM EDT
Gore Completes First in-Human Implants of the GORE VIAFORT Vascular Stent
W. L. Gore & Associates

W. L. Gore & Associates initiates its GORE® VIAFORT Device Pivotal Clinical Study for the treatment of inferior vena cava occlusive disease.

Released: 28-Oct-2022 8:05 AM EDT
ScienceMedia Joins Forces with Leading Advocate for Life Sciences in California

ScienceMedia has joined Biocom California at the Provider level of membership, connecting to more than 1,700 member companies and 500,000 employees across California and beyond.

Released: 27-Oct-2022 1:05 PM EDT
Finalists Named for the 2022 Hearst Health Prize in Partnership with the UCLA Center for SMART Health
Hearst Health

The UCLA Center for SMART Health, an interdisciplinary collaborative that looks to the integrated transformation of healthcare through emergent data and technologies, and Hearst Health, a division of Hearst and leader in care guidance, today announced the three finalists for the 2022 Hearst Health Prize, a $100,000 award given in recognition of excellence in data science for managing or improving health in the U.S.

Released: 27-Oct-2022 9:00 AM EDT
United BioChannels Acquires ORFLO Technologies to Expand Market Share and Enhance Customer Engagement
United BioChannels

United BioChannels (UBC), a commercial strategy consultancy, announced its acquisition of ORFLO Technologies, LLC, from Gemini Bioproducts.

Released: 27-Oct-2022 8:05 AM EDT
Hazel Health Accelerates Growth to Over 3,000 Schools in 14 States, Secures Series C1 Funding
Hazel Health

School-based telehealth provider releases impact report following one year of dramatic expansion during the nation's youth mental health crisis.

Released: 26-Oct-2022 11:35 AM EDT
Advanced Radio Technology Startup Announces Move to West Virginia
Civil-Military Innovation Institute Inc.

Xtremis, LLC (Xtremis), a Nashville-based startup developing advanced, Artificial Intelligence control systems that improve the performance of wireless networks in congested RF environments, recently announced its intention to relocate to Morgantown, WV.

Released: 25-Oct-2022 12:55 PM EDT
COUR Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for Myasthenia Gravis
COUR Pharmaceuticals

COUR Pharmaceuticals, a clinical-stage biotechnology company developing novel immune-modifying nanoparticles designed to reprogram the immune system for the treatment of autoimmune disorders (COUR NanoParticles or CNPs), today announced that the U.S. Food and Drug Administration has cleared an Investigational New Drug (IND) application to initiate a Phase 1b/2a proof-of-concept study of COUR's investigational therapy, CNP-106.

Released: 25-Oct-2022 12:05 PM EDT
ImageSource Inc. Revitalizes with New Website
ImageSource, Inc.

Process-innovation leader ImageSource, Inc. has rolled out a new flagship website at

Released: 18-Oct-2022 4:05 PM EDT
Vasa Therapeutics Announces Upcoming Presentations at AHA Scientific Sessions 2022
Vasa Therapeutics, Inc.

Vasa Therapeutics, Inc., a preclinical stage company developing first-in-class treatments for cardiovascular indications with limited or no available therapies, today announced two upcoming poster presentations showing data on the company's lead clinical candidate, VS-041, a selective matrix metalloprotease (MMP) inhibitor for treatment of heart failure with preserved ejection fraction (HFpEF) and the discovery of novel calcium/calmodulin-dependent protein kinase II delta (CaMKIIδ) inhibitors for treatment of β-blocker resistant arrythmias, at the American Heart Association (AHA) Scientific Sessions November 5 – 7 in Chicago, IL.

Released: 18-Oct-2022 10:45 AM EDT
Vilcek Foundation Awards $600,000 in Prizes to Immigrant Scientists and Musicians
Vilcek Foundation

The Vilcek Foundation announces the recipients of the 2023 Vilcek Foundation Prizes. Awarded annually in the arts and sciences, the prizes recognize and celebrate immigrant contributions to the arts, culture, and society, and build awareness of how important immigration is for intellectual and cultural life in the United States.

Released: 12-Oct-2022 4:55 PM EDT
5th Year in a Row, SIA Ranks GQR #7 Fastest-Growing U.S. Staffing Firm
GQR Global Markets

GQR Global Markets announced today that it has been named #7 on Staffing Industry Analysts' (SIA) 2022 List of Fastest-Growing Staffing Firms for the 5th year in a row. Even more exceptional is the fact that GQR is the only firm to rank in the top ten for four of the last five years and within the top sixteen every year for the last five years.

Released: 23-Sep-2022 8:05 AM EDT
Riverside Oral Surgery Named One of New Jersey's Best Places to Work
Riverside Oral Surgery

Riverside Oral Surgery, the premier oral and maxillofacial surgery group in New Jersey, has been named one of the Best Places to Work (medium market employer) in 2022 by NJBIZ.

Released: 15-Sep-2022 2:05 PM EDT
CME Outfitters Announces Partnership with National Black Church Initiative
CME Outfitters

Partnership will deliver healthcare education and resources to an estimated 27.7 million members of the African- American and Latino communities on a multitude of therapeutic areas and disease states.

Released: 9-Sep-2022 9:45 AM EDT
Mold Awareness Month Creator Reiterates Need for Indoor Air Quality Vigilance

It's likely many Americans think of September as the start of football season or the beginning of a new school year.

Released: 24-Aug-2022 8:50 AM EDT
Synthetic Medical Imaging: How Deepfakes Could Improve Healthcare

Retrace, a leader in dental artificial intelligence and provider of digital infrastructure for U.S. healthcare, announces the publication, "A generative adversarial inpainting network to enhance prediction of periodontal clinical attachment level" in the August 2022 Edition of the Journal of Dentistry.

Released: 24-Aug-2022 8:05 AM EDT
Lactose-reduced infant formulas made with corn syrup solids are associated with higher obesity risk among children
Heluna Health

Lactose-reduced infant formula made with corn syrup solids was associated with higher obesity risk among Special Supplemental Nutrition Program for Women, Infants and Children (WIC) participants in Southern California, according to a new study by researchers from Public Health Foundation Enterprises (PHFE) WIC, a program of Heluna Health; and Children's Hospital Los Angeles.

Released: 22-Aug-2022 10:25 AM EDT
American Physical Society Appoints Rachel Burley Chief Publications Officer
American Physical Society (APS)

The American Physical Society (APS), publisher of the prestigious Physical Review journals, has appointed Rachel Burley as its first Chief Publications Officer (CPO). In this new role, Burley will manage more than a dozen leading peer-reviewed journals.

Released: 15-Aug-2022 8:05 AM EDT
Avails Medical announces the commencement of U.S. Pivotal Clinical Trials for eQUANT
Avails Medical, Inc.

Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (eAST™) announced today the commencement of U.S. pivotal clinical trials for its eQUANT system, which will be used to support a submission for FDA clearance.

Released: 9-Aug-2022 12:20 PM EDT
Top Criminologist and University Leader Joins the National Policing Institute
National Policing Institute

The National Policing Institute (the Institute) is proud to announce and welcome Robin S. Engel, PhD as the Institute's Senior Vice President, becoming the second highest-ranking executive within the national non-profit research and policy organization dedicated to excellence in policing and community safety through science and innovation.


Showing results

150 of 481